Nuvectis Pharma, Inc. ( NVCT) - Key Metrics
NVCT Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.30 | -$0.19 | -$0.19 |
| 2026Q1 | $0 | -$0.26 | -$0.28 | -$0.28 |
| 2025Q4 | $0 | -$0.34 | -$0.18 | -$0.18 |
| 2025Q3 | $0 | -$0.33 | -$0.20 | -$0.20 |
| 2025Q2 | $0 | -$0.30 | -$0.16 | -$0.16 |
NVCT Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -15.33 |
| 2026Q1 | 0% | -7.43 |
| 2025Q4 | 0% | -6.09 |
| 2025Q3 | 0% | -3.42 |
| 2025Q2 | 0% | -6.23 |
NVCT
Price: $23.35
52 week price:
Earnings Per Share: -1.32 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 617.4 million